MULTIPLEXED SENSITIVE TESTING FOR DRUGS OF ABUSE

Award Information

Agency: Department of Health and Human Services	Branch: N/A	Award ID: 96549	Program Year/Program: 2010 / SBIR
Agency Tracking Number: N43DA201000012	Solicitation Year: N/A	Solicitation Topic Code: NIDA	Solicitation Number: N/A

Small Business Information: BIOMEDOMICS, INC.
6 DAVIS DRIVE RESEARCH TRIANGLE PARK, NC 27709-
View profile »

Woman-Owned: No

Minority-Owned: Yes

HUBZone-Owned: No

Phase 1: Fiscal Year: 2010

Title: MULTIPLEXED SENSITIVE TESTING FOR DRUGS OF ABUSE

Agency: HHS

Contract: N43DA201000012

Award Amount: $99,989.00

Abstract:
Most drugs of abuse (DOA) testing is performed in a central lab that requires the shipping of specimens, expensive equipment (GC/MS/LS), long turnaround times, and uses valuable staff resources with current testing. Current DOA point of care (POC) assays used as pre-screening assays are generally not as sensitive or accurate as GC/MS/LS, and often times requires extra staff according to specific guidelines.

Principal Investigator:
Frank Wang

Small Business Information at Submission:

BIOMEDOMICS, INC.
6 DAVIS DRIVE RESEARCH TRIANGLE PARK, NC 27709-

EIN/Tax ID: 205795824

DUNS: N/A

Number of Employees: N/A

Woman-Owned: No

Minority-Owned: Yes

HUBZone-Owned: No